{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:48:26Z","timestamp":1788850106036,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A series of [1,2]oxazolo[5,4\u2010<jats:italic>e<\/jats:italic>]isoindole derivatives was evaluated against HL\u201060 cell line and its multidrug resistance\u00a0(MDR) variant, HL\u201060R, resistant to doxorubicin and to other P\u2010gp substrates by overexpressing the efflux pump. They displayed antiproliferative activities, with IC<jats:sub>50<\/jats:sub> values ranging from 0.02 to 5.5\u2009\u00b5M. In particular, the newly synthesized compound <jats:bold>4k<\/jats:bold> produced synergistic effects in terms of cell growth inhibition and cell death induction either in combination with a Vinca alkaloid, Vinblastine, and a Taxane, Paclitaxel in HL\u201060R cells. The study of the mechanism of action indicated that all compounds showed antimitotic activity through inhibition of tubulin polymerization. Thus, [1,2]oxazoles could represent a valuable tool to overcome MDR mechanism, confirming the potential use of this class of compounds.<\/jats:p>","DOI":"10.1002\/ddr.21962","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T16:43:50Z","timestamp":1656089030000},"page":"1331-1341","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Novel insights on [1,2]oxazolo[5,4\u2010<i>e<\/i>]isoindoles on multidrug resistant acute myeloid leukemia cell line"],"prefix":"10.1002","volume":"83","author":[{"given":"Manuela","family":"Labbozzetta","sequence":"first","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Barreca","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Span\u00f2","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-738X","authenticated-orcid":false,"given":"Maria Valeria","family":"Raimondi","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-9893","authenticated-orcid":false,"given":"Paola","family":"Poma","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Notarbartolo","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Barraja","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Montalbano","sequence":"additional","affiliation":[{"name":"Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF) University of Palermo Palermo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00255753"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1192"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(20)31181-3"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100645"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.01.096"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107552"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00600"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114399"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(20)31165-5"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15115"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114292"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100681"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S134529"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23988"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.291"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04163-7"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2009.06.005"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030356"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199807000-00008"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(01)00834-5"},{"key":"e_1_2_6_23_1","first-page":"133","article-title":"Expression of the IAPs in multidrug resistant tumor cells","volume":"11","author":"Notarbartolo M.","year":"2004","journal-title":"Oncology Reports"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16354"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2015.1078026"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.087452"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800051055"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00777"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.09.013"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01315"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1984"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.02.001"},{"issue":"2","key":"e_1_2_6_33_1","first-page":"369","article-title":"PAK\u2010104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein","volume":"2","author":"Vanhoefer U.","year":"1996","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2903-8"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01457"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4380-4"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.21739"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S191621"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21962","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ddr.21962","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:48:40Z","timestamp":1760377720000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/ddr.21962"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21962","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"2022-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}